| 000 | 01833cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030750.0 | ||
| 008 | 130212s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.29.M.Sc.2012.Mo.P | ||
| 100 | 0 | _aMohamed Mahmoud Ahmed Ahmed | |
| 245 | 1 | 0 |
_aPossible effect of omeprazole , pantoprazole and ranitidine on the antiplatelet activity of clopidogrel in albino rats and mice / _cMohamed Mahmoud Ahmed Ahmed ; Supervised Ebtissam Abdelghaffar Metwally , Essam Fouad Alalkamy |
| 246 | 1 | 5 | _aالتأثير المحتمل للأوميبرازول والبانتوبرازول والرانيتيدين على وظيفة عقار الكلوبيدوجريل كمضاد للصفائح الدموية فى الفئران والجرذان البيضاء |
| 260 |
_aCairo : _bMohamed Mahmoud Ahmed Ahmed , _c2012 |
||
| 300 |
_a101P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pharmacology | ||
| 520 | _aStudies have raised concerns that many proton pump inhibitors (PPIs) , especially ompeprazole might diminish the antiplatelet effects and the clinical effectiveness of clopidogrel . By contrast , a preliminary report of data from another trial did find an association between use of a PPI in combination with clopidogrel and an increased risk of adverse outcomes | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAntiplatelet | |
| 653 | 4 | _aClopidogrel | |
| 653 | 4 | _aOmeprazole | |
| 700 | 0 |
_aEbtissam Abdelghaffar Metwally , _eSupervisor |
|
| 700 | 0 |
_aEssam Fouad Alalkamy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c41451 _d41451 |
||